Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02675608 · ClinicalTrials.gov registry record
Vaccine Efficacy in Diabetic and Elderly Patients
A clinical trial of Inflammation, sponsored by Tulane University.
- Completed
- Registry status
- 164
- Enrollment target
- 1
- Study location
NCT02675608 is a study of Inflammation that has completed, run by Tulane University. The registered enrollment target is 164 participants, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02675608, a study of Inflammation, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effectiveness of the seasonal flu vaccine in adults of different ages and diabetic disease statuses. These studies will help our understanding of how chronic inflammatory diseases impact immunologic function and future research on mitigation strategies.
Conditions Studied
Interventions
- BIOLOGICAL Influenza Virus Vaccine
Study Locations (1)
Louisiana
- Tulane Clinical Translational Unit - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02675608
The ClinicalTrials.gov registry entry for NCT02675608 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (43% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Influenza Virus Vaccine is the first listed.
NCT02675608 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT02675608 about?
NCT02675608 is a clinical study titled "Vaccine Efficacy in Diabetic and Elderly Patients". This study evaluates the effectiveness of the seasonal flu vaccine in adults of different ages and diabetic disease statuses. These studies will help our understanding of how chronic inflammatory diseases impact immunologic function and future research on mitigation strategies.
What is the current status of trial NCT02675608?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2015-08.
What conditions does trial NCT02675608 study?
This clinical trial studies the following conditions: Inflammation.
What interventions are being tested in trial NCT02675608?
The interventions under investigation include: Influenza Virus Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02675608?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02675608 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.